For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.
Sep 25, 2023
0
8
A new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide ...
Sep 22, 2023
0
9
Puberty in both girls and boys with type 1 diabetes has shifted forward over the last two decades, according to research presented at the 61st Annual European Society for Pediatric Endocrinology Meeting in The Hague. Additionally ...
Sep 22, 2023
0
9
Type 1 diabetes is an autoimmune disease, often with onset during childhood, that requires lifelong insulin therapy due to the loss of pancreatic beta-cells.
Sep 21, 2023
0
1
Childhood-onset type 1 diabetes (onset
Sep 21, 2023
0
8
New research published in Diabetologia shows that morning and afternoon physical activity are associated with a lower risk of developing type 2 diabetes across all population levels of education and income, but has found ...
Sep 20, 2023
0
21
Type 2 diabetes (T2D) is characterized by persistent hyperglycemia (high glucose in blood) that leads to hypoxia (low oxygen condition) in pancreatic β-cells.
Sep 20, 2023
0
0
Low-carb diets may be all the rage, but they're not for kids with diabetes, according to the American Academy of Pediatrics (AAP).
Sep 18, 2023
0
4
Islet transplantation significantly reduces the risk of transplantation failure and enhances life expectancy in individuals with type 1 diabetes who undergo kidney transplantation, a new study has revealed.
Sep 16, 2023
0
5
A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024—subject to availability.
Sep 15, 2023
0
5
